Nosocomial infections amongst critically ill COVID-19 patients in Australia

Purpose: To determine the frequency of nosocomial infections including hospital-acquired pneumonia (HAP) and bloodstream infection (BSI), amongst critically ill patients with COVID-19 infection in Australian ICUs and to evaluate associations with mortality and length of stay (LOS). Methods: The effe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mahesh Ramanan, Aidan Burrell, Eldho Paul, Tony Trapani, Tessa Broadley, Steve McGloughlin, Craig French, Andrew Udy
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/98ef3d0f0e7a474997041c64b84007e0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:98ef3d0f0e7a474997041c64b84007e0
record_format dspace
spelling oai:doaj.org-article:98ef3d0f0e7a474997041c64b84007e02021-11-20T05:16:00ZNosocomial infections amongst critically ill COVID-19 patients in Australia2667-038010.1016/j.jcvp.2021.100054https://doaj.org/article/98ef3d0f0e7a474997041c64b84007e02021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2667038021000466https://doaj.org/toc/2667-0380Purpose: To determine the frequency of nosocomial infections including hospital-acquired pneumonia (HAP) and bloodstream infection (BSI), amongst critically ill patients with COVID-19 infection in Australian ICUs and to evaluate associations with mortality and length of stay (LOS). Methods: The effect of nosocomial infections on hospital mortality was evaluated using hierarchical logistic regression models to adjust for illness severity and mechanical ventilation. Results: There were 490 patients admitted to 55 ICUs during the study period. Adjusted odds ratio (OR) for hospital mortality was 1.61 (95% confidence interval (CI) 0.61–4.27, p = 0.3) when considering BSI, and 1.76 (95% CI 0.73–4.21, p = 0.2) for HAP. The average adjusted ICU LOS was significantly longer for patients with BSI (geometric mean 9.0 days vs 6.3 days, p = 0.04) and HAP (geometric mean 13.9 days vs 6.0 days p<0.001). Conclusion: Nosocomial infection rates amongst patients with COVID-19 were low and their development was associated with a significantly longer ICU LOS.Mahesh RamananAidan BurrellEldho PaulTony TrapaniTessa BroadleySteve McGloughlinCraig FrenchAndrew UdyElsevierarticleCOVID-19Critical careBloodstream infectionsNosocomial infectionsHealthcare-associated pneumoniaInfectious and parasitic diseasesRC109-216ENJournal of Clinical Virology Plus, Vol 1, Iss 4, Pp 100054- (2021)
institution DOAJ
collection DOAJ
language EN
topic COVID-19
Critical care
Bloodstream infections
Nosocomial infections
Healthcare-associated pneumonia
Infectious and parasitic diseases
RC109-216
spellingShingle COVID-19
Critical care
Bloodstream infections
Nosocomial infections
Healthcare-associated pneumonia
Infectious and parasitic diseases
RC109-216
Mahesh Ramanan
Aidan Burrell
Eldho Paul
Tony Trapani
Tessa Broadley
Steve McGloughlin
Craig French
Andrew Udy
Nosocomial infections amongst critically ill COVID-19 patients in Australia
description Purpose: To determine the frequency of nosocomial infections including hospital-acquired pneumonia (HAP) and bloodstream infection (BSI), amongst critically ill patients with COVID-19 infection in Australian ICUs and to evaluate associations with mortality and length of stay (LOS). Methods: The effect of nosocomial infections on hospital mortality was evaluated using hierarchical logistic regression models to adjust for illness severity and mechanical ventilation. Results: There were 490 patients admitted to 55 ICUs during the study period. Adjusted odds ratio (OR) for hospital mortality was 1.61 (95% confidence interval (CI) 0.61–4.27, p = 0.3) when considering BSI, and 1.76 (95% CI 0.73–4.21, p = 0.2) for HAP. The average adjusted ICU LOS was significantly longer for patients with BSI (geometric mean 9.0 days vs 6.3 days, p = 0.04) and HAP (geometric mean 13.9 days vs 6.0 days p<0.001). Conclusion: Nosocomial infection rates amongst patients with COVID-19 were low and their development was associated with a significantly longer ICU LOS.
format article
author Mahesh Ramanan
Aidan Burrell
Eldho Paul
Tony Trapani
Tessa Broadley
Steve McGloughlin
Craig French
Andrew Udy
author_facet Mahesh Ramanan
Aidan Burrell
Eldho Paul
Tony Trapani
Tessa Broadley
Steve McGloughlin
Craig French
Andrew Udy
author_sort Mahesh Ramanan
title Nosocomial infections amongst critically ill COVID-19 patients in Australia
title_short Nosocomial infections amongst critically ill COVID-19 patients in Australia
title_full Nosocomial infections amongst critically ill COVID-19 patients in Australia
title_fullStr Nosocomial infections amongst critically ill COVID-19 patients in Australia
title_full_unstemmed Nosocomial infections amongst critically ill COVID-19 patients in Australia
title_sort nosocomial infections amongst critically ill covid-19 patients in australia
publisher Elsevier
publishDate 2021
url https://doaj.org/article/98ef3d0f0e7a474997041c64b84007e0
work_keys_str_mv AT maheshramanan nosocomialinfectionsamongstcriticallyillcovid19patientsinaustralia
AT aidanburrell nosocomialinfectionsamongstcriticallyillcovid19patientsinaustralia
AT eldhopaul nosocomialinfectionsamongstcriticallyillcovid19patientsinaustralia
AT tonytrapani nosocomialinfectionsamongstcriticallyillcovid19patientsinaustralia
AT tessabroadley nosocomialinfectionsamongstcriticallyillcovid19patientsinaustralia
AT stevemcgloughlin nosocomialinfectionsamongstcriticallyillcovid19patientsinaustralia
AT craigfrench nosocomialinfectionsamongstcriticallyillcovid19patientsinaustralia
AT andrewudy nosocomialinfectionsamongstcriticallyillcovid19patientsinaustralia
_version_ 1718419496963670016